Potent in vitro Neutralization of SARS-CoV-2 by Hetero-bivalent Alpaca Nanobodies Targeting the Spike Receptor-Binding Domain
Huan Ma(University of Science and Technology of China), Tengchuan Jin(Anhui Medical University), Weihong Zeng(Hefei University of Technology), Xiaowen Hu(Lanzhou University), Changcheng Zhao(University of Science and Technology of China), Peigen Zhou(University of Wisconsin–Madison), Pei‐Hui Wang(Shandong University), Yan Xiang(Sichuan University), Xiaofang Wang(Dalian Institute of Chemical Physics), Xiaoxue Huang(University of Science and Technology of China), Dan Zhao(Wuhan University), Huichao Ou(University of Science and Technology of China), Yunru Yang(University of Science and Technology of China), Yong Sun(Zhejiang Chinese Medical University), Xiangzhi Meng(University of California, Los Angeles)
Cited by 3
Related Papers
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin L
|Science Advances|2020|400
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
|Cellular and Molecular Immunology|2020|376
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
|Proceedings of the National Academy of Sciences|2013|342
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
|Frontiers in Chemistry|2021|311
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling
|Signal Transduction and Targeted Therapy|2020|301